Zooplankton biomass and indices of feeding and metabolism in relation to an upwelling filament off northwest Africa

Zooplankton biomass and indices of grazing (gut fluorescence), respiration (electron transfer system activity, ETS) and growth (aspartate transcarbamylase, ATC) were studied in relation to an upwelling filament off northwest Africa during August 1993. The filament extended 150 km offshore into the oligotrophic waters. It was generated by a trapped, quasi-permanent cyclonic eddy located between the Canary Islands and the African shelf. High biomass, specific gut fluorescence and electron transfer system activity in zooplankton were observed along the filament structure. In contrast, low values of biomass, gut fluorescence, ETS and ATC specific activities were found in the center of the trapped cyclonic eddy. Assuming a 50% of pigment destruction, the calculated grazing impact of zooplankton on primary production varied between 16 and 97%, a high range compared to other oceanic systems. Ingestion, estimated from indices of metabolism and growth, accounted for 47–296% of the primary production (assuming an herbivorous feeding). Mesozooplankton transported offshore into the oligotrophic area fulfilled their metabolic demands with nonpigmented food as observed from the increase of omnivory from the coastal waters to the open ocean. The progressive decay of grazing and metabolic indices along the filament suggests that advection, rather than local enrichment processes, is mostly responsible for the high biomass values in this physical structure

Omics and multi-omics analysis for the early identification and improved outcome of patients with psoriatic arthritis

The definitive diagnosis and early treatment of many immune-mediated inflammatory diseases (IMIDs) is hindered by variable and overlapping clinical manifestations. Psoriatic arthritis (PsA), which develops in ~30% of people with psoriasis, is a key example. This mixed-pattern IMID is apparent in entheseal and synovial musculoskeletal structures, but a definitive diagnosis often can only be made by clinical experts or when an extensive progressive disease state is apparent. As with other IMIDs, the detection of multimodal molecular biomarkers offers some hope for the early diagnosis of PsA and the initiation of effective management and treatment strategies. However, specific biomarkers are not yet available for PsA. The assessment of new markers by genomic and epigenomic profiling, or the analysis of blood and synovial fluid/tissue samples using proteomics, metabolomics and lipidomics, provides hope that complex molecular biomarker profiles could be developed to diagnose PsA. Importantly, the integration of these markers with high-throughput histology, imaging and standardized clinical assessment data provides an important opportunity to develop molecular profiles that could improve the diagnosis of PsA, predict its occurrence in cohorts of individuals with psoriasis, differentiate PsA from other IMIDs, and improve therapeutic responses. In this review, we consider the technologies that are currently deployed in the EU IMI2 project HIPPOCRATES to define biomarker profiles specific for PsA and discuss the advantages of combining multi-omics data to improve the outcome of PsA patients

Exercise-induced changes in bioactive lipids might serve as potential predictors of post-exercise hypotension. A pilot study in healthy volunteers

Post-exercise hypotension (PEH) is the phenomenon of lowered blood pressure after a single bout of exercise. Only a fraction of people develops PEH but its occurrence correlates well with long-term effects of sports on blood pressure. Therefore, PEH has been suggested as a suitable predictor for the effectivity of exercise as therapy in hypertension. Local vascular bioactive lipids might play a potential role in this context. We performed a cross-over clinical pilot study with 18 healthy volunteers to investigate the occurrence of PEH after a single short-term endurance exercise. Furthermore, we investigated the plasma lipid profile with focus on arachidonic acid (AA)-derived metabolites as potential biomarkers of PEH. A single bout of ergometer cycling induced a significant PEH in healthy volunteers with the expected high inter-individual variability. Targeted lipid spectrum analysis revealed significant upregulation of several lipids in the direct post-exercise phase. Among these changes, only 15- hydroxyeicosatetranoic acid (HETE) correlated significantly with the extent of PEH but in an AA-independent manner, suggesting that 15-HETE might act as specific PEH-marker. Our data indicate that specific lipid modulation might facilitate the identification of patients who will benefit from exercise activity in hypertension therapy. However, larger trials including hypertonic patients are necessary to verify the clinical value of this hypothesis